Singapore-based healthcare firm Clearbridge Health Limited debuted on the Catalist, the growth board of the Singapore Exchange (SGX) on 18 December, Monday, at its issue price. Post-listing, the firm is valued at S$134.7 million ($99.8 million).
Continue reading this story with a subscription to DealStreetAsia.
Already a subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com.
